Page 180 - Genentech News Today

Pancreatic cancer has proven resistant to immunotherapy in the past, but personalized mRNA vaccines may overcome that problem.

/PRNewswire/ -- Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today three new appointments to...

Rising prevalence of neurological, psychological, and other speech-related diseases is a significant factor driving global speech biomarkers market

When researchers compared patients who met treatment criteria, treatment initiation was similar across races and socioeconomic status. But that finding raises other questions.

Acumen Research and Consulting recently published report titled “Allergy Treatment Market Forecast, 2023 - 2032”...

Customers using PagerDuty AIOps saw an average of 87% noise reduction and deployed automated incident response 9x faster than existing solutions ... | April 11, 2023

Dr. Francisco Lopera found in Antioquia clues that have helped uncover the causes of early-onset Alzheimer's and eventually prevent the gene from mutating.

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t

/PRNewswire/ -- The "Global Alzheimers Therapeutics Market (2022-2027) by Diagnostics, Drug Class, Distribution, and Geography, Competitive Analysis and the...

The company bulks up its pipeline by regaining the rights to two of its clinical programs.